Crista Galli Ventures is a European venture capital firm that invests in early-stage (Seed and Series A) healthtech companies, focusing on deep tech, digital health, and personalized medicine. Their strategy involves providing patient capital and leveraging their physician-led expertise to back founders with clinician-led insights who are addressing real-world healthcare challenges.
80% of their portfolio is in Healthcare. Their most common stage is seed (60% of deals). Average disclosed round size is $7.7M (across 5 rounds with reported amounts).
Portfolio
5
Fund Size
$65M
Top Stage
Seed
Last 12 Mo
0
Portfolio Breakdown
Stage Distribution
Sector Distribution
Investment Activity
DealsAvg Round Size
Portfolio
5 investments
| Company | Round | Amount | Date |
|---|---|---|---|
 Vitrue Health | Seed | $4M | Mar 2024 |
| Vitrue Health | Seed | $3.7M | Feb 2024 |
 Pear Bio | Series A | $14M | May 2023 |
 Anja Health | Seed | $4.5M | May 2022 |
 Subtle Medical | Series A | $12.2M | Nov 2020 |
Top Co-Investors
MMC Ventures2 shared
Hambro Perks2 shared
Simplyhealth Ventures1 shared
3E Bioventures Capital1 shared
Fusion Fund1 shared
Data Collective1 shared
Tsingyuan Ventures1 shared
Nina Capital1 shared
Octopus Ventures1 shared
Hoxton Ventures1 shared
SOSV1 shared
Fly Ventures1 shared
Compound1 shared
Seven Seven Six1 shared
Last updated: 8 March 2026